OQROGet OQRO Pro
Insider trade

Ars Pharmaceuticals (SPRY)CHIEF MEDICAL OFFICER sold ~$658K

Sarina Tanimoto, CHIEF MEDICAL OFFICER at Ars Pharmaceuticals, sold ~$658K of Ars Pharmaceuticals shares.

~$658K
Approx. value · 50K sh @ $13.16
1.15M
Holds after · shares reported
Traded
Dec 10, 2024
Filed
Dec 11, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 15, 2024Insider · 2 peopleInsiders: 6 sales (~$3.0M)
  2. Oct 16, 2024InsiderCFO sold ~$200K of SPRY shares in the open market
  3. Nov 11, 2024Insider · 1 personInsiders: 4 sales (~$9.5M)
  4. Nov 12, 2024Insider · 3 peopleInsiders: 12 sales (~$4.0M)
  5. Nov 19, 2024Insider · 2 peopleInsiders: 4 sales (~$2.8M)
  6. Nov 25, 2024InsiderOfficer sold ~$459K of SPRY shares in the open market
  7. Nov 26, 2024InsiderOfficer sold ~$593K of SPRY shares in the open market
  8. Nov 27, 2024InsiderOfficer sold ~$360K of SPRY shares in the open market
  9. Dec 2, 2024Insider · 3 peopleInsiders: 4 sales (~$2.0M)
  10. Dec 3, 2024Insider · 2 peopleInsiders: 2 sales (~$1.8M)
  11. Dec 4, 2024Insider · 3 peopleInsiders: 3 sales (~$919K)
  12. Dec 5, 2024InsiderOfficer sold ~$702K of SPRY shares in the open market
  13. Dec 6, 2024InsiderOfficer sold ~$712K of SPRY shares in the open market
  14. Dec 10, 2024 · this disclosureInsiderOfficer sold ~$658K of SPRY shares in the open market

What came next

  1. Dec 10, 2024Insider · 3 peopleInsiders: 4 sales (~$2.6M)
  2. Dec 11, 2024InsiderOfficer sold ~$186K of SPRY shares in the open market
  3. Dec 12, 2024Insider · 2 peopleInsiders: 2 sales (~$1.7M)
  4. Dec 13, 2024InsiderOfficer sold ~$329K of SPRY shares in the open market
  5. Dec 17, 2024Insider · 2 peopleInsiders: 4 sales (~$2.3M)
  6. Jan 6, 2025InsiderDirector sold ~$555K of SPRY shares in the open market
  7. Feb 3, 2025InsiderDirector sold ~$616K of SPRY shares in the open market
  8. Mar 5, 2025InsiderDirector sold ~$4.4K of SPRY shares in the open market
  9. Mar 6, 2025InsiderDirector sold ~$556K of SPRY shares in the open market
  10. Mar 20, 2025InsiderOfficer sold ~$140K of SPRY shares in the open market
  11. Apr 7, 2025InsiderDirector sold ~$615K of SPRY shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ars Pharmaceuticals

For Ars Pharmaceuticals, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SPRY page.

Other recent filings by Sarina Tanimoto, CHIEF MEDICAL OFFICER

The full history of Sarina Tanimoto, CHIEF MEDICAL OFFICER is on the profile page.

How this filing works

Other disclosures at Ars Pharmaceuticals

Everything OQRO holds on this company is on its SPRY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data